...
Disease | Congenital heart defects | |||||
---|---|---|---|---|---|---|
Inheritance | Autosomal dominant | |||||
Prevalence
| Common Source: | |||||
Rapid or full curation? |
| |||||
ClinGen (dosage) - little evidence for haploinsufficiency / triploinsufficiency. No GenCC curations. HGMD entries below. | ||||||
Clinical Validity Scoring Notes and points | c.655G>T p.E219* - absent gnomAD. NMD+, PMID: 30232381 - reported as Glu39* in proband TOF241 with TOF, RAA, bicuspid pulmonic valve; short stature, obesity; learning difficulties; depression and/or anxiety; stillborn offspring. 1 POINT (COMMON) c.454C>T p.R152* - absent gnomAD, NMD +, PMID: 20420808 - in patient 2 with Left ventricular outflow tract obstruction BAV, AVS, CoA,PDA, ascending aorta dilation. Also inherited from unaffected family members, and they only sequenced VEGFA, so would decrease points for both. 0.5 POINT c.19_22dupGACA p.(Thr8Argfs*78 - variant in 0.04% (23/39188) East Asian chr gAD v4. PMID: 20420808 - Present in patient with coarctation of the aorta, VSD and PDA. High MAF, also inherited from unaffected family members, and they only sequenced VEGFA, will not score points for this variant. c.998G>A p.R333Q - 7/44788 East Asian chr. REVEL score is not in gAD. PMID: 20420808 - Found in one proband with coarctation of the aorta and vsd, but variant inherited from unaffected family members, and they only sequenced this gene. Deduct points. 0.5 POINT c.973C>T p.R325* - 0.002% (35/1156678) European alleles gnomAD. PMID: 22067973 - found in a patient with isolated tricuspid aortic valve stenosis, but inherited from unaffected parent, VEGFA only gene sequenced. Deduct points. 0.5 POINT PMID: 33620155 - increased VEGF applied to quail embryos shown to lead to impaired heart tube elongation accompanied by diameter expansion. VEGF treatment increased the rate of cardiac malformations in surviving embryos. Shows some potential impact of VEGF and congenital heart defects, but applying endogenous VEGF is not replicating the LOF model proposed in humans (based on the variants reported above). 0.5 points | |||||
Clinical Validity Points Total | 2.5 3 point | |||||
Clinical Validity Classification
| Limited | |||||
Molecular Mechanism
| Loss of function / Gain of function / Dominant Negative | |||||
Penetrance
(list source/PMID) | Source: | |||||
Age of Onset
(list source/PMID) | ||||||
Severity
| ||||||
Clinical Features | Sources: | |||||
HPO Terms | ||||||
Gene SOPs & Notes | LINK if SOP is a long document. Short notes if it is easy to digest. eg. Last known truncating variant | |||||
Curation Summary
| ||||||
Case ID, Curator name, Date, Jira ticket link | E3730537808, Andrea Oza, 02.06.24 |
...